Detailed Information on Publication Record
2023
Assessment of plasma protein C activity in dogs with portosystemic shunt
NEČASOVÁ, Andrea, Jana LORENZOVÁ, Kristína ŘEHÁKOVÁ, Danka HARUŠTIAKOVÁ, Alois NEČAS et. al.Basic information
Original name
Assessment of plasma protein C activity in dogs with portosystemic shunt
Authors
NEČASOVÁ, Andrea, Jana LORENZOVÁ, Kristína ŘEHÁKOVÁ, Danka HARUŠTIAKOVÁ (703 Slovakia, belonging to the institution) and Alois NEČAS
Edition
Acta Veterinaria Brno, Brno, University of Veterinary and Pharmaceutical Sciences, 2023, 0001-7213
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
40301 Veterinary science
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 0.600 in 2022
RIV identification code
RIV/00216224:14310/23:00133639
Organization unit
Faculty of Science
UT WoS
001153359000009
Keywords in English
Canine; vascular anomaly; ameroid constrictor; liver; prognostic marker
Tags
International impact, Reviewed
Změněno: 1/3/2024 10:35, Mgr. Marie Šípková, DiS.
Abstract
V originále
Portosystemic shunt (PSS) is a vascular disease that can be treated by various surgical techniques. Current veterinary studies are evaluating new prognostic markers in dogs with PSS. This study aims at evaluating the prognostic value of plasma protein C activity in dogs (n = 34) with PSS treated surgically using an ameroid constrictor. Plasma protein C activity was measured in the following time periods: preoperatively (T1), 2 days after surgery (T2), 8 weeks after surgery (T3) and > 6 months after surgery (T4). There was a significant increase in plasma protein C activity between T1/T2 and T3/T4 (P < 0.001). There was no significant relationship between the plasma protein C activity and sex (P = 0.676), age (P = 0.172), breed (P = 0.573), type of clinical signs (neurological P = 0.993; gastrointestinal P = 0.924; urological P = 0.385) and type of portosystemic shunt (P = 0.516), except for dogs with a caval type of extrahepatic PSS termination that had significant lower plasma protein C activity values compared to dogs with a diaphragmatic type of extrahepatic PSS (P = 0.031). No significant relationship was found between plasma protein C activity and the probability of the dog's death (P = 0.334) or the dog's clinical outcome (P = 0.960). Although not a prognostic factor, protein C activity is a laboratory marker that is useful for the diagnosis of PSS in dogs and can also be helpful in the postoperative monitoring.